home / stock / aconw / aconw quote
Last: | $0.0583 |
---|---|
Change Percent: | -24.08% |
Open: | $0.0644 |
Close: | $0.0583 |
High: | $0.0644 |
Low: | $0.03 |
Volume: | 52,991 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0583 | $0.0644 | $0.0583 | $0.0644 | $0.03 | 52,991 | 05-02-2024 |
$0.0519 | $0.053 | $0.0519 | $0.053 | $0.0519 | 32,021 | 05-01-2024 |
$0.0602 | $0.0648 | $0.0602 | $0.067024 | $0.0521 | 26,199 | 04-30-2024 |
$0.064 | $0.14 | $0.064 | $0.14 | $0.0431 | 35,542 | 04-29-2024 |
$0.05 | $0.07 | $0.05 | $0.07 | $0.04 | 86,090 | 04-26-2024 |
$0.082 | $0.028999 | $0.082 | $0.1303 | $0.028999 | 697,024 | 04-25-2024 |
$0.029 | $0.02617 | $0.029 | $0.029 | $0.02617 | 4,800 | 04-24-2024 |
$0.0279 | $0.02595 | $0.0279 | $0.0279 | $0.02595 | 3,200 | 04-23-2024 |
$0.026 | $0.023 | $0.026 | $0.026 | $0.02 | 2,054 | 04-19-2024 |
$0.023 | $0.0259 | $0.023 | $0.026 | $0.023 | 1,206 | 04-18-2024 |
$0.0265 | $0.0299 | $0.0265 | $0.0299 | $0.0265 | 4,755 | 04-17-2024 |
$0.0259 | $0 | $0.0259 | $0 | $0 | 76 | 04-15-2024 |
$0.0259 | $0.0292 | $0.0259 | $0.0292 | $0.0259 | 370 | 04-12-2024 |
$0.0279 | $0.028 | $0.0279 | $0.028 | $0.0252 | 53,910 | 04-11-2024 |
$0.0265 | $0.044 | $0.0265 | $0.044 | $0.0265 | 2,643 | 04-10-2024 |
$0.025 | $0.025 | $0.025 | $0.03 | $0.0249 | 48,429 | 04-09-2024 |
$0.043 | $0.041 | $0.043 | $0.043 | $0.041 | 535 | 04-03-2024 |
$0.041 | $0.041 | $0.041 | $0.041 | $0.041 | 245 | 04-02-2024 |
$0.04 | $0.03 | $0.04 | $0.041 | $0.03 | 9,000 | 04-01-2024 |
$0.035 | $0.035 | $0.035 | $0.035 | $0.035 | 101 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aclarion Inc. Warrant Company Name:
ACONW Stock Symbol:
NASDAQ Market:
LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a single-payer national health insurance system LIFEHAB is targeting enrollment to begin in the second quarter of 2024 BROOMFIELD, CO,...
Confirms predictive value of Nociscan for identifying painful discs. Nociscan demonstrated a sensitivity of 100% and a specificity of 80% compared to provocative discography (PD), suggesting Nociscan provides better information to surgeons. BROOMFIELD, CO, March 04, 2024 (GLOBE NEWS...
BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW) , a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help...